Network Penetration Testing for Biotech companies in Newark
Network Penetration Testing for Biotech Companies in Newark
Biotech companies in Newark and across New Jersey handle highly sensitive data: clinical trial results, genomic data, proprietary formulas, and confidential partner information. This makes local labs, research facilities, and life science startups prime targets for ransomware groups, insider threats, and financially motivated hackers.
Common cyberattacks against biotech organizations include malware, phishing, password attacks, SQL injection, and targeted ransomware aimed at disrupting research, stealing intellectual property, or compromising regulated data. The cost of a breach is substantial — the median global cost of a data breach in 2021 reached $4.24M, and that number does not account for unreported incidents, lost drug pipeline value, or delayed time-to-market.
For Newark-based biotech companies working with hospitals, CROs, and universities in the New Jersey–New York corridor, regular network penetration testing is no longer optional. It is a practical way to verify that firewalls, cloud environments, lab networks, VPNs, and remote access used by researchers are actually protecting your data and supporting compliance with HIPAA, FDA, GxP, and other regulatory expectations.
Network penetration testing (sometimes called “net-pen testing” or simply “pentest”) is a controlled, ethical hacking exercise where security specialists simulate real-world attacks on your IT and lab networks. The goal is to identify and safely exploit vulnerabilities before a criminal does — and then provide clear remediation steps your internal IT or security team can actually implement.
Newark Biotech Network Penetration Testing Experience
OCD Tech provides network penetration testing services for biotech and life sciences organizations in Newark and across New Jersey. Our team has experience working with:
Biotech startups operating out of Newark innovation hubs and shared lab spaces
Research laboratories and CROs collaborating with New Jersey and New York medical centers
Pharma and medical device manufacturers with regulated and validated environments
We combine practical offensive security experience with an understanding of regulated biotech environments — including segmented lab networks, instrument controllers, cloud-based analysis platforms, and collaboration tools used for data sharing. The outcome is a targeted security assessment that not only exposes weaknesses, but also explains business impact in plain language: what a real attacker could do, how quickly, and how to stop it.
Each network penetration test includes prioritized, actionable recommendations so leadership, IT, and security teams can close gaps efficiently while maintaining uptime for research and production.
Network Penetration Testing Methodology
OCD Tech follows a structured, repeatable penetration testing methodology aligned with industry best practices. For biotech organizations, we adapt our approach to consider lab networks, remote researchers, cloud-based analysis, and third-party data flows. Our process includes:
Passive Reconnaissance – Quietly gathering information about your organization, technology stack, and exposure without interacting directly with systems.
Active Reconnaissance – Safely scanning and mapping networks, lab segments, cloud services, and critical systems to identify potential entry points.
Social Engineering – With your approval, testing how susceptible staff may be to phishing or manipulation that could expose VPN access, credentials, or research data.
Exploitation – Attempting to exploit identified weaknesses (for example, misconfigurations, missing patches, or weak access controls) in a controlled and documented manner.
Post-Exploitation – Determining what an attacker could realistically do after gaining access: viewing sample data, moving into lab networks, or reaching sensitive file shares.
Privilege Escalation – Testing whether initial access can be escalated to admin or domain-wide control, which would be catastrophic in a biotech environment.
Lateral Movement – Assessing how easily an attacker could move between corporate IT, R&D networks, lab environments, and cloud platforms.
Maintaining Access – Demonstrating how an attacker might quietly persist inside your environment without detection.
Covering Tracks – Showing which logs or alerts could be bypassed or removed, to help your Blue Team improve monitoring and incident response.
Reporting – Delivering a clear, structured report that explains what we did, what we found, the real-world risk, and step-by-step remediation guidance for both technical and non-technical stakeholders.
Where useful, we can coordinate with your internal teams in a Red Team / Blue Team / Purple Team style engagement to test both your defenses and your detection/response capabilities.
National Reach with Local Focus
While we work extensively with Newark and New Jersey biotech companies, OCD Tech also provides network penetration testing services across the U.S., including:
For multi-site biotech organizations, this allows for a consistent security assessment approach across all locations, with local understanding of regulatory and operational constraints.
Contact Our Newark Network Penetration Testing Consultants
OCD Tech provides network penetration testing and cybersecurity consulting to biotech and life sciences organizations in Newark and throughout New Jersey. If you want to understand how an attacker would actually target your environment — and how to stop them — complete the form below and a team member will contact you to discuss a tailored penetration test for your organization.
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)
.svg)